Cancer Commons News and Events

Jude LaCava Promotes Cancer Commons During Hockey Fights Cancer Event

November 6, 2017

Hear from some more cancer fighters: Avid @ArizonaCoyotes fan Tom (Labonte) from Chandler and @judefox10 #YotesFightCancer — FOX Sports Arizona (@FOXSPORTSAZ) November 5, 2017 Fox 10 News sports anchor Jude LaCava is a long-time proponent of Cancer Commons who has sent many patients and caregivers our way to receive extra guidance for their cancer treatment, including Super Patient Mary Beth Smith. This past weekend,… Read more »

Thank You to the H8 Cancer Foundation

November 6, 2017

We at Cancer Commons express our deep gratitude to the H8 Cancer Foundation, which has generously made our organization a major beneficiary of its gifts since 2015. Founded by oncologist Dr. Simeon Jaggernauth, H8 Cancer is “dedicated to raising funds for research and to promote awareness of better treatment options to save lives.” Recently, we had the honor of attending Tomstock, an annual summer music festival to benefit H8… Read more »

The Economist Publishes Cancer Commons Founder Marty Tenenbaum’s Letter to the Editor

October 12, 2017

Cancer Commons founder Marty Tenenbaum wrote a letter to the editor that has now been published in The Economist. His piece discusses the importance of using data to accelerate improvement of cancer treatment. From the letter: “The oncology drug pipeline is full of promising immunotherapies and targeted treatments (Technology Quarterly on cancer, September 16th). Unfortunately, no one knows the optimal way to use them. Doctors and patients… Read more »

“Rockin’ for a Cure” at Tomstock 2017

September 5, 2017

A little more than four years ago, longtime friends Tom and Carman Duvall, and Kiers and Steve Rowley reminisced at dinner about their lives in the 1980s, long before their schedules had grown complicated and filled with endless trips driving children to various activities. Tom, a child of 1980s rock and roll, wondered aloud whether Def Leppard might perform for them on his next… Read more »

Deloitte Colleagues Raise Over $300,000 in Support of Cancer Commons

August 8, 2017

In 2014, a dedicated team of Deloitte colleagues joined forces to help cancer patients find the best treatment options for optimal outcomes. They made their first gifts to Cancer Commons in memory of Jackie Tran. Ms. Tran was a Deloitte partner who received support from Cancer Commons’ ASK service while navigating her treatment options for ovarian cancer. Since then, over $300,000 has been raised… Read more »

ASK Cancer Commons has International Impact

August 8, 2017

Cancer Commons provides expert, personalized guidance to patients and caregivers around the world through our ASK Cancer Commons service. Recently, we plotted the distribution of our ASK users on a world map to see where they live. We found that about 2,000 people in more than 44 countries have sought help from Cancer Commons. “Cancer Commons is catering to an international audience and therefore… Read more »

BioQuick News Covers Marty Tenenbaum’s Recent PMWC Presentation

June 10, 2017

A new article from BioQuick News discusses Cancer Commons founder Marty Tenenbaum’s presentation at last week’s Personalized Medicine World Conference: In the PMWC 2017 discussion, Dr. Tenenbaum focused on the question: When faced with certain death, is it acceptable to accept less than 100% proven safety and efficacy? Patients with glioblastoma and certain other cancers with dire prognoses do not have the time to… Read more »

Image credit: Caroline Davis2010

Medical Director Kevin Knopf Discusses Cancer Commons in Xconomy Article

June 10, 2017

In a recent Xconomy article on cancer DNA testing, Cancer Commons medical director Kevin Knopf shares his perspective: “To help all patients we think an open-source database has the most utility,” says Knopf. Instead of current tests that list a patient’s mutations and potential drugs to use, a report should rank therapies the way online travel sites rank best options. Read the full article… Read more »

Marty Tenenbaum Presents a New Path to FDA Drug Approval at PMWC

June 6, 2017

Last week, Cancer Commons founder Marty Tenenbaum spoke at the Precision Medicine World Conference (PMWC) in Durham, NC. He presented a proposal to significantly accelerate patient access to promising investigational drugs, using a new pathway to approval by the U.S. Food and Drug Administration (FDA). The proposed Conditional Approval pathway aims to help cancer patients who may have exhausted existing options access new, promising treatments. “It’s… Read more »

Cancer Commons Community Member Spotlight: Sheri Sobrato Brisson

May 2, 2017

Since the beginning of high school, Cancer Commons supporter Sheri Sobrato Brisson has been working with families facing pediatric illness. “As soon as I was 16, I started volunteering in hospitals with kids with cancer, not knowing that I would grow up one day to be one of those patients myself,” she says. At the age of 24, Sheri faced her own diagnosis: a… Read more »